South America Singleplex Immunoassay Market

ID: MRFR/HC/54380-HCR
200 Pages
Nidhi Mandole
Last Updated: February 06, 2026
South America Singleplex Immunoassay Market Research Report By Product and Service (Consumables, Instruments, Others), By Type (Protein-Based Assays, Nucleic Acid Based Assays, Cell-Based Assays, Others), By Technology (Flow Cytometry, Fluorescence Detection), By Application (Research & Development, Drug Discovery & Development, Biomarker Discovery & Validation, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Metabolism & Endocrinology Disorders, Others), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals and Research Institutes, Reference Laboratories, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035
South America Singleplex Immunoassay Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.48%
2024 Market Size$ 9.85 Million
2025 Market Size$ 10.09 Million
2035 Market Size$ 12.9 Million
Key Players
Thermo Fisher Scientific
Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Merck KGaA
Bio-Rad Laboratories
Trends
  • Technological Advancements
  • Regulatory Support
  • Rising Healthcare Expenditure
Opportunities
  • Supportive Government Initiatives
  • Focus on Infectious Disease Management
  • Increasing Demand for Diagnostic Testing
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Product and Service (USD Million)
      1. 4.1.1 Consumables
      2. 4.1.2 Instruments
      3. 4.1.3 Others
    2. 4.2 Construction, BY Type (USD Million)
      1. 4.2.1 Protein-Based Assays
      2. 4.2.2 Nucleic Acid Based Assays
      3. 4.2.3 Cell-Based Assays
      4. 4.2.4 Others
    3. 4.3 Construction, BY Technology (USD Million)
      1. 4.3.1 Flow Cytometry
      2. 4.3.2 Fluorescence Detection
      3. 4.3.3 Others
    4. 4.4 Construction, BY Application (USD Million)
      1. 4.4.1 Research & Development
      2. 4.4.2 Clinical Diagnostics
      3. 4.4.3 Others
    5. 4.5 Construction, BY End-user (USD Million)
      1. 4.5.1 Pharmaceutical & Biotechnology Companies
      2. 4.5.2 Hospitals & Research Institutes
      3. 4.5.3 Reference Laboratories
      4. 4.5.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Thermo Fisher Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott Laboratories (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Roche Diagnostics (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Siemens Healthineers (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Merck KGaA (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Bio-Rad Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Ortho Clinical Diagnostics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 PerkinElmer (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT AND SERVICE
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY TYPE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    6. 6.6 SOUTH AMERICA MARKET ANALYSIS BY END-USER
    7. 6.7 KEY BUYING CRITERIA OF CONSTRUCTION
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF CONSTRUCTION
    10. 6.10 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    12. 6.12 SUPPLY / VALUE CHAIN: CONSTRUCTION
    13. 6.13 CONSTRUCTION, BY PRODUCT AND SERVICE, 2024 (% SHARE)
    14. 6.14 CONSTRUCTION, BY PRODUCT AND SERVICE, 2024 TO 2035 (USD Million)
    15. 6.15 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    16. 6.16 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 CONSTRUCTION, BY TECHNOLOGY, 2024 (% SHARE)
    18. 6.18 CONSTRUCTION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    19. 6.19 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    20. 6.20 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    21. 6.21 CONSTRUCTION, BY END-USER, 2024 (% SHARE)
    22. 6.22 CONSTRUCTION, BY END-USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Million)
      2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America Construction Market Segmentation

Construction By Product and Service (USD Million, 2025-2035)

  • Consumables
  • Instruments
  • Others

Construction By Type (USD Million, 2025-2035)

  • Protein-Based Assays
  • Nucleic Acid Based Assays
  • Cell-Based Assays
  • Others

Construction By Technology (USD Million, 2025-2035)

  • Flow Cytometry
  • Fluorescence Detection
  • Others

Construction By Application (USD Million, 2025-2035)

  • Research & Development
  • Clinical Diagnostics
  • Others

Construction By End-user (USD Million, 2025-2035)

  • South America Singleplex Immunoassay Market & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.